How are Pharmaceutical clinical supply chains changing to improve? In a recent article at Reuters, they share how Pharma companies are leading the effort to boost profits, reduce counterfeit drugs, and even moving their drug production closer to the demand populations. This helps the Pharma companies boost their profit margins and reduce their transportation costs, in addition to utilizing logistics firms to improve their ability to change their production to the demand of the market.
This fall at the Clinical Business Expo, the Global Clinical Trial Supply Chain Management event will host the session "Overcome the Challenges of Maintaining the Drug Supply Chain" which will look at many of the issues spotlighted in this article. For more information on this event, download the agenda. If you'd like to join us September 19-20, register to join us and mention code XP1725BLOG to save 15% off the standard rate. You can also register for the pre-conference workshop on September 18 "The 3rd Annual Strategic Clinical Trial Supply Chain Management Consortium."
How do you see the global clinical supply chain landscape changing? Do you believe more companies are bringing their production closer to home to reduce transportation costs and counterfeiting?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.